The global lung cancer surgery market is projected to grow significantly, with its valuation expected to rise from USD 1.4 billion in 2024 to USD 2.5 billion by 2034, expanding at a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of lung cancer worldwide, …
Continue reading “Lung Cancer Surgery Industry to Reach USD 2.5 Billion by 2034 at a 5.7% of CAGR”